Background:
        Limited data exist regarding clinical outcomes of multiple chronic total occlusions (CTOs) according to therapeutic strategies, coronary artery bypass grafting (CABG), percutaneous coronary intervention (PCI), and medical treatment (MT).
      
          
        Methods:
        From March 2003 to February 2012, a total of 2024 patients with at least one CTO were enrolled in retrospective, single-center registry. 393 patients with at least two CTOs were categorized based on the intention-to-treat principle. Propensity-score matching was performed. The primary outcome was major adverse cardiac and cerebral events (MACCE).
      
          
        Results:
        Of 393 patients with multiple CTOs, 169 patients (43%) were referred for CABG, 130 (33%) for PCI, and 94 (24%) for MT. Median overall follow-up duration was 46.5 (interquartile range 22.7 to 74.6) months. After propensity-score matching analysis, CABG had lower rates of MACCE when compared with PCI (HR=0.43, 0.21-0.85, P=0.01) and MT (HR=0.10, 0.04-0.27, P<0.01). Rates of repeat revascularization was significantly lower in CABG, compared with PCI (HR=0.05, 0.01-0.40, P<0.01) and MT (HR=0.01, 0.00-0.54, P=0.02). CABG had similar rates of cardiac death compared with PCI group (HR=0.97, 0.37-2.53, P=0.95), but had significantly lower rates of cardiac death compared with MT (HR=0.24, 0.08-0.75, P=0.01).
      
          
        Conclusions:
        For management of multiple CTOs, MT alone was associated with higher incidence of cardiac death and MACCE compared with CABG. PCI was associated with higher incidence of MACCE, as driven by higher repeat revascularization rate. These findings suggest that CABG might be associated with better clinical outcome and considered as the preferred treatment strategy in patients with multiple CTOs.
      
       
          
          
                      
              
  Citing Articles
                              
  Percutaneous Coronary Intervention versus Coronary Artery Bypass Grafting for Chronic Total Occlusion of Coronary Arteries: A Systematic Review and Meta-Analysis.
  
    Wang C, Liu S, Kamronbek R, Ni S, Cheng Y, Yan H
    
    
    J Interv Cardiol. 2023; 2023:9928347.
  
  
    PMID: 37965179
    
          PMC: 10643034.
    
          DOI: 10.1155/2023/9928347.
      
 
                                  
                                              
  Evaluation of Oxidative Status in Elderly Patients with Multiple Cerebral Infarctions and Multiple Chronic Total Coronary Occlusions.
  
    Li X, Guo D, Hu Y, Chen Y
    
    
    Dis Markers. 2022; 2022:2083990.
  
  
    PMID: 35801004
    
          PMC: 9256345.
    
          DOI: 10.1155/2022/2083990.
      
 
                                  
                                              
  Effect of revascularization on coronary chronic total occlusion in patients undergoing coronary artery bypass grafting.
  
    Lee J, Kim Y, Kim H, Kang J, Song H, Lim J
    
    
    J Thorac Dis. 2022; 13(11):6343-6352.
  
  
    PMID: 34992814
    
          PMC: 8662467.
    
          DOI: 10.21037/jtd-21-681.
      
 
                                  
                                              
  Late Survival Benefit of Percutaneous Coronary Intervention Compared With Medical Therapy in Patients With Coronary Chronic Total Occlusion: A 10-Year Follow-Up Study.
  
    Park T, Lee S, Choi K, Lee J, Yang J, Song Y
    
    
    J Am Heart Assoc. 2021; 10(6):e019022.
  
  
    PMID: 33660515
    
          PMC: 8174228.
    
          DOI: 10.1161/JAHA.120.019022.
      
 
                                  
                                              
  Long term clinical impact of successful recanalization of chronic total occlusion in patients with and without type 2 diabetes mellitus.
  
    Tsai C, Huang W, Teng H, Tsai Y, Lu T
    
    
    Cardiovasc Diabetol. 2020; 19(1):119.
  
  
    PMID: 32738906
    
          PMC: 7395357.
    
          DOI: 10.1186/s12933-020-01093-6.
      
 
                              
              
                              
                
                
                                      
  The success of opening concurrent chronic total occlusion lesion to improve cardiac function trial in patients with multi-vessel disease (SOS-moral): Study protocol of a prospective multicenter study.
  
    Tian J, Zuo H, Zhang L, Zhang M, Zhang D, Zhang M
    
    
    Medicine (Baltimore). 2020; 99(21):e20349.
  
  
    PMID: 32481325
    
          PMC: 7249893.
    
          DOI: 10.1097/MD.0000000000020349.
      
 
                                          
                                                          
  Percutaneous Coronary Intervention Versus Medical Therapy for Chronic Total Occlusion of Coronary Arteries: A Systematic Review and Meta-Analysis.
  
    Li K, Wong K, Gong M, Liu T, Li G, Xia Y
    
    
    Curr Atheroscler Rep. 2019; 21(10):42.
  
  
    PMID: 31399762
    
          PMC: 6689032.
    
          DOI: 10.1007/s11883-019-0804-8.
      
 
                                          
                                                          
  Successful treatment of complex coronary chronic total occlusions improves midterm outcomes.
  
    Wu K, Huang Z, Zhong Z, Liao H, Zhou Y, Luo B
    
    
    Ann Transl Med. 2019; 7(9):194.
  
  
    PMID: 31205912
    
          PMC: 6545308.
    
          DOI: 10.21037/atm.2019.05.09.
      
 
                                          
                                                          
  Outcomes of Chronic Total Occlusions in Coronary Arteries According to Three Therapeutic Strategies: A Meta-analysis with 6985 Patients from 8 Published Observational Studies.
  
    Zheng Y, Gao Y, Chen Y, Wu T, Ma Y, Zhang J
    
    
    Braz J Cardiovasc Surg. 2019; 34(6):645-652.
  
  
    PMID: 31194477
    
          PMC: 6894022.
    
          DOI: 10.21470/1678-9741-2018-0176.
      
 
                                          
                                                          
  Chemical suppression of specific C-C chemokine signaling pathways enhances cardiac reprogramming.
  
    Guo Y, Lei I, Tian S, Gao W, Hacer K, Li Y
    
    
    J Biol Chem. 2019; 294(23):9134-9146.
  
  
    PMID: 31023824
    
          PMC: 6556576.
    
          DOI: 10.1074/jbc.RA118.006000.
      
 
                                          
                                                          
  HDAC inhibitor valproic acid protects heart function through Foxm1 pathway after acute myocardial infarction.
  
    Tian S, Lei I, Gao W, Liu L, Guo Y, Creech J
    
    
    EBioMedicine. 2018; 39:83-94.
  
  
    PMID: 30552062
    
          PMC: 6354709.
    
          DOI: 10.1016/j.ebiom.2018.12.003.
      
 
                                          
                                                          
  Association of β-blocker therapy with long-term clinical outcomes in patients with coronary chronic total occlusion.
  
    Hwang J, Yang J, Hwang J, Jang W, Song Y, Hahn J
    
    
    Medicine (Baltimore). 2016; 95(30):e4300.
  
  
    PMID: 27472704
    
          PMC: 5265841.
    
          DOI: 10.1097/MD.0000000000004300.
      
 
                                          
                                                          
  Should Chronic Total Occlusion Be Treated With Coronary Artery Bypass Grafting? Chronic Total Occlusion Should Not Routinely Be Treated With Coronary Artery Bypass Grafting.
  
    Weintraub W, Garratt K
    
    
    Circulation. 2016; 133(18):1818-25.
  
  
    PMID: 27143549
    
          PMC: 5505506.
    
          DOI: 10.1161/CIRCULATIONAHA.115.017798.